PEGS Boston 2019 will host more than 400 lectures, panels, tutorials and round-table discussions, along with 150+ exhibitors, and 300 research posters on display in the exhibit hall. The speaker lineup includes world-renowned experts, visionaries, and influencers from top pharma, biotech, academic, and government institutions.
Abzena will be exhibiting at stand 701 and Abzena’s SVP Scientific Operations – Campbell Bunce will be presenting on:
Evaluating Specificity, Immunogenicity, Functionality & Manufacturability For Lead Candidate Selection
Understand the latest series of in silico computational models, analytics, in vitro and ex vivo experiments used in developability assessment. Characterise a molecules Specificity, Immunogenicity, Safety, Functionality and Manufacturability. Data generated informs sequence, structural, formulation and process refinements to select the best candidate for manufacture.